SCHEMBL6997260

SCHEMBL6997260

Nc1c(Cl)cc(Nc2ncnc3cnc(N[C@H]4CC[C@H](C(=O)N5CCOCC5)CC4)nc23)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.51
ERBB2 P04626 2/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
BTK Q06187 1/20 0.49
SYK P43405 4/20 0.46
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
MAPK10 P53779 1/20 0.43
BRAF P15056 4/20 0.42
DYRK1A Q13627 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
PIK3CA P42336 2/20 0.40
PIK3CD O00329 1/20 0.40
PIK3R1 P27986 1/20 0.40
LRRK2 Q5S007 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
AKT1 P31749 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997256 1.00 EGFR (0.51) EGFRERBB2HPGDHTTBTK
SCHEMBL6987987 0.93 EGFR (0.53) EGFRERBB2HPGDHTTBTK
SCHEMBL6987985 0.93 EGFR (0.53) EGFRERBB2HPGDHTTBTK
SCHEMBL14040852 0.92 EGFR (0.53) EGFRERBB2HPGDHTTBTK
SCHEMBL8314679 0.90 EGFR (0.57) EGFRERBB2HPGDHTTBTK
SCHEMBL8314682 0.90 EGFR (0.57) EGFRERBB2HPGDHTTBTK
SCHEMBL6994172 0.88 EGFR (0.69) EGFRERBB2HPGDHTTBTK
SCHEMBL6994175 0.88 EGFR (0.69) EGFRERBB2HPGDHTTBTK
SCHEMBL8457941 0.86 EGFR (0.53) EGFRERBB2HPGDHTTBTK
SCHEMBL8457936 0.86 EGFR (0.53) EGFRERBB2HPGDHTTBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP claimed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP claimed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed